Board Meeting6 Nov 2026, 07:23 pm
Aanjaay Industries Declares Q2 FY27 Un-audited Financials
AI Summary
Aanjaay Industries Limited (formerly Kabra Drugs Limited) announced the outcome of its Board Meeting held on November 6, 2026. The Board considered and approved the un-audited financial statements for the quarter ended September 30, 2026, along with the limited review report from the statutory auditors. The company also stated that Regulation 32 of SEBI (LODR) Regulations, 2015, regarding statements of deviation or variation, is not applicable as no shares were issued via public issue, rights issue, or preferential issue. The meeting commenced at 5:00 p.m. IST and concluded at 7:00 p.m. IST.
Key Highlights
- Board approved un-audited financial statements for Q2 FY27.
- Limited review report from statutory auditors was obtained.
- Regulation 32 of SEBI (LODR) Regulations, 2015, deemed not applicable.
- Company has not issued shares via public, rights, or preferential issues.
- Board meeting held on November 6, 2026.
Price Impact
More from KABRADG